Advanced glycation end-products - Open Access .click

Results 241 to 250 of about 49,218 (259)

Some of the next articles are maybe not open access.

Advanced Glycation End Products in Peritoneal Dialysis

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 1996
openaire +2 more sources

Advanced Glycation End Products in Neurodegenerative Diseases

Journal of Molecular Neuroscience
Advanced glycation end products (AGEs) have attracted interest as therapeutic targets for neurodegenerative diseases. AGEs facilitate the onset and progression of various neurogenerative disorders due to their ability to promote cross-linking and aggregation of proteins.
openaire +2 more sources

Comparison of metabolic fate, target organs, and microbiota interactions of free and bound dietary advanced glycation end products

Critical Reviews in Food Science and Nutrition, 2023
Min Zhang, Huicui Liu, Xiaojin Yuan
exaly

Role of advanced glycation end products and insulin resistance in diabetic nephropathy

Archives of Physiology and Biochemistry, 2023
Palash Mandal, Kirti Parwani
exaly

Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD

Respiratory Medicine, 2011
Peter N Black
exaly

Increased methylglyoxal and advanced glycation end products in kidney from spontaneously hypertensive rats

Kidney International, 2004
Kaushik Desai, Lingyun Wu
exaly

Clinical/Translational Aspects of Advanced Glycation End-Products

Trends in Endocrinology and Metabolism, 2019
Franklin Tay, Lina Niu
exaly

Advanced glycation end-products (AGEs) in foods and their detecting techniques and methods: A review

Trends in Food Science and Technology, 2018
Da-Wen Sun
exaly